Association of Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic Melanoma : a Retrospective Case-control Study.
NCT04760080
·
clinicaltrials.gov ↗
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Dermatology and Oncology
Interventions
OTHER:
pre-treatment data
OTHER:
during study treatment
Sponsor
Hospices Civils de Lyon